Chuang Chao-Hua, Doyle Pat, Wang Jung-Der, Chang Pei-Jen, Lai Jung-Nien, Chen Pau-Chung
Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan.
Drug Saf. 2006;29(6):537-48. doi: 10.2165/00002018-200629060-00006.
Major congenital malformations place a considerable burden on the affected child, the family and society. Any kind of medicine used during pregnancy might have a harmful impact; therefore, such practice has raised concerns. The objective of the current study was to explore the relationship between the use of herbal medicines by pregnant women during the first trimester of pregnancy and the risk of major congenital malformation in their live born infants.
This was a cross-sectional analysis of data from a prospective pregnancy cohort, which was established between 1984 and 1987. To assemble the cohort, pregnant women of >or=26 weeks of gestation who came to the Taipei Municipal Maternal and Child Hospital in Taiwan for prenatal care were enrolled in the study and interviewed using a structured questionnaire. Detailed information, including herbal medicine use during different periods of pregnancy, was obtained during the interview. Past medical history, current obstetric data and details on conventional medicines used during pregnancy were abstracted from medical records. Data on birth weight, gestational duration and characteristics of live born infants were gathered from the Taiwan national birth register. Congenital malformation information was obtained from multiple sources: the newborn examination record (1984-7); the national death register (1984-2003); and Taiwan National Health Insurance data (1996-2000). Multiple logistic regression was used to estimate the odds ratio [OR] of major congenital malformation by herbal medicines used during the first trimester.
A total of 14,551 live births were analysed. After adjustment for confounding factors, taking huanglian during the first trimester of pregnancy was found to be associated with increased risk of congenital malformations of the nervous system (adjusted OR 8.62, 95% CI 2.54, 29.24). An-Tai-Yin was associated with an increased risk of congenital malformations of the musculoskeletal and connective tissues (adjusted OR 1.61, 95% CI 1.10, 2.36) and the eye (adjusted OR 7.30, 95% CI 1.47, 36.18).
We found evidence for a possible link between the use of specific herbal medicines during the first trimester of pregnancy and increased risks of specific groups of congenital malformations. We could not investigate whether the adverse effects were related to direct toxicity from the herbal medicines, or were from misuse, contamination or uncontrolled confounding. Nonetheless, we would advise caution regarding use of herbal medicines during pregnancy, and we suggest that further investigation of these findings is warranted.
严重先天性畸形给患病儿童、家庭和社会带来了相当大的负担。孕期使用的任何药物都可能产生有害影响;因此,这种做法引发了人们的担忧。本研究的目的是探讨孕妇在妊娠早期使用草药与她们活产婴儿发生严重先天性畸形风险之间的关系。
这是一项对前瞻性妊娠队列数据的横断面分析,该队列于1984年至1987年建立。为组建该队列,将妊娠≥26周、前往台湾台北市立妇幼医院进行产前检查的孕妇纳入研究,并使用结构化问卷进行访谈。在访谈过程中获取了详细信息,包括孕期不同阶段使用草药的情况。从病历中提取了既往病史、当前产科数据以及孕期使用的常规药物的详细信息。从台湾国家出生登记处收集了出生体重、孕周和活产婴儿特征的数据。先天性畸形信息来自多个来源:新生儿检查记录(1984 - 1987年);国家死亡登记处(1984 - 2003年);以及台湾国民健康保险数据(1996 - 2000年)。采用多因素逻辑回归分析来估计妊娠早期使用草药导致严重先天性畸形的比值比(OR)。
共分析了14551例活产病例。在对混杂因素进行调整后,发现妊娠早期服用黄连与神经系统先天性畸形风险增加相关(调整后OR 8.62,95%可信区间2.54,29.24)。安胎饮与肌肉骨骼和结缔组织先天性畸形风险增加(调整后OR 1.61,95%可信区间1.10,2.36)以及眼部先天性畸形风险增加(调整后OR 7.30,95%可信区间1.47,36.18)相关。
我们发现有证据表明妊娠早期使用特定草药与特定类型先天性畸形风险增加之间可能存在关联。我们无法调查这些不良反应是与草药的直接毒性有关,还是由于误用、污染或未控制的混杂因素所致。尽管如此,我们建议孕期使用草药时要谨慎,并认为有必要对这些发现进行进一步研究。